| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
| mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
BRD-K19103580 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
AGK-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |